v3 Template
M

MannKind Corporation

Biotechnology and Pharmaceuticals Danbury, Conn. and Westlake Village, Calif. ~500 employees
Founded
--
Employees (Est.)
~500
25 leaders known
Total Funding
$650.0M
Funding Rounds
2
Last Funding
2025-08-06

About MannKind Corporation

MannKind Corporation is committed to developing and commercializing innovative therapeutic products and devices for people living with endocrine and orphan lung diseases. Their approach leverages cutting-edge technology and is driven by solutions-based scientists and medical professionals dedicated to helping individuals live life more humanely.

Products & Services

Afrezza® (insulin human) Inhalation Powder:An inhaled insulin for diabetes management, with full prescribing information available on the product website.
V-Go®:An all-in-one insulin delivery patch for daily insulin administration, with detailed safety and usage information provided.
Tyvaso DPI® (treprostinil) Inhalation Powder:An FDA-approved product utilizing MannKind's Technosphere inhalation technology for the treatment of pulmonary conditions, in collaboration with United Therapeutics.

Specialties

Inhaled Therapeutic Products Endocrine Disease Treatments Orphan Lung Disease Treatments Technosphere Inhalation Technology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Debt
T: -
FT: Debt 		A: 500000000
MR: -
FA: up to $500 million
FAN: 500000000 		D: 2025-08-06
FD: 2025-08-06 		1 investors
2 RT: Royalty Purchase
T: -
FT: Royalty Purchase 		A: 150000000
MR: -
FA: $150 million
FAN: 150000000 		D: 2024-01-02
FD: 2024-01-02 		1 investors
Debt Latest
2025-08-06
$500.0M
1 investor (Pro only)
Royalty Purchase 2024-01-02
$150.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

A

Alfred E. Mann

Visionary in aerospace, medical technology, and biopharmaceuticals

M

Michael Castagna

Chief Executive Officer

LinkedIn (Pro only)
C

Chris Prentiss

Chief Financial Officer

D

Dominic Marasco

President, Endocrine Business Unit

S

Sanjay Singh

Executive Vice President, Technical Operations MannKind

D

David Thomson

General Counsel and Corporate Secretary

View 22 more team members with Pro

Unlock Full Team Directory

Recent News

MannKind Corporation Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology and Pharmaceuticals
Company Size
~500 employees (est.)
Locations
Danbury, Conn. and Westlake Village, Calif.
DANBURY, Conn. and WESTLAKE VILLAGE, Calif.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro